Manning Meredithinsider trades

In SEC Form 4 filings, Manning Meredith is listed as Director of Unicycive Therapeutics, Inc. (UNCY). Manning Meredith reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 29.

Companies and roles

Company	Role	Transactions	Last filed
UNCYUnicycive Therapeutics, Inc.	Director	2	Oct 29

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-29

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
UNCYUnicycive Therapeutics, Inc.	Oct 28	Oct 29	A · derivative	3,350	$0.00	$0	3,350	No	Form 4
UNCYUnicycive Therapeutics, Inc.	Oct 28	Oct 29	A · derivative	27,000	$3.76	$101,520	27,000	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.